Recent Advances in Fungal Infections: From Lung Ecology to Therapeutic Strategies With a Focus on Aspergillus spp.
Fiche du document
2022
- doi: 10.3389/fmed.2022.832510
- issn: 2296-858X
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.3389/fmed.2022.832510
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/35386908
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/2296-858X
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_DB72BBC66F140
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Sujets proches
Fungal infections Fungous diseases Mycotic diseases Fungal diseases Mycotic infections MycosisCiter ce document
F. Palmieri et al., « Recent Advances in Fungal Infections: From Lung Ecology to Therapeutic Strategies With a Focus on Aspergillus spp. », Serveur académique Lausannois, ID : 10.3389/fmed.2022.832510
Métriques
Partage / Export
Résumé
Fungal infections are estimated to be the main cause of death for more than 1.5 million people worldwide annually. However, fungal pathogenicity has been largely neglected. This is notably the case for pulmonary fungal infections, which are difficult to diagnose and to treat. We are currently facing a global emergence of antifungal resistance, which decreases the chances of survival for affected patients. New therapeutic approaches are therefore needed to face these life-threatening fungal infections. In this review, we will provide a general overview on respiratory fungal infections, with a focus on fungi of the genus Aspergillus. Next, the immunological and microbiological mechanisms of fungal pathogenesis will be discussed. The role of the respiratory mycobiota and its interactions with the bacterial microbiota on lung fungal infections will be presented from an ecological perspective. Finally, we will focus on existing and future innovative approaches for the treatment of respiratory fungal infections.